Showing results (21-30 of 64) with videos related to

Sort By:
Pageof 7
Pharmacoeconomics|July 26, 2014
Rituximab in combination with corticosteroids for the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis: a NICE single technology appraisalNicholas R Latimer, Christopher Carroll, Ruth Wong, et al.
BMC Medical Research Methodology|August 27, 2016
The use of rapid review methods in health technology assessments: 3 case studiesEva Kaltenthaler, Katy Cooper, Abdullah Pandor, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|October 25, 2019
Statistical Methods for Adjusting Estimates of Treatment Effectiveness for Patient Nonadherence in the Context of Time-to-Event Outcomes and Health Technology Assessment: A Systematic Review of Methodological PapersAbualbishr Alshreef, Nicholas Latimer, Paul Tappenden, et al.
Health Technology Assessment (Winchester, England)|March 4, 2020
Interventions to reduce the risk of surgically transmitted Creutzfeldt-Jakob disease: a cost-effective modelling reviewMatt Stevenson, Lesley Uttley, Jeremy E Oakley, et al.
BMC Public Health|April 18, 2015
Sexual health risk reduction interventions for people with severe mental illness: a systematic reviewAbdullah Pandor, Eva Kaltenthaler, Agnes Higgins, et al.
Applied Health Economics and Health Policy|April 5, 2019
An Updated Systematic Review of Studies Mapping (or Cross-Walking) Measures of Health-Related Quality of Life to Generic Preference-Based Measures to Generate Utility ValuesClara Mukuria, Donna Rowen, Sue Harnan, et al.
Pharmacoeconomics|May 29, 2015
Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group PerspectiveEmma L Simpson, Sarah Davis, Praveen Thokala, et al.
Pharmacoeconomics|December 13, 2016
Degarelix for Treating Advanced Hormone-Dependent Prostate Cancer: An Evidence Review Group Perspective of a NICE Single Technology AppraisalLesley Uttley, Sophie Whyte, Timothy Gomersall, et al.
BMJ Open|July 19, 2014
The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic reviewEdith Poku, John Rathbone, Ruth Wong, et al.
Pharmacoeconomics|March 5, 2018
Baricitinib for Previously Treated Moderate or Severe Rheumatoid Arthritis: An Evidence Review Group Perspective of a NICE Single Technology AppraisalShijie Ren, Iñigo Bermejo, Emma Simpson, et al.
Pageof 7